Haemonetics Corporation
HAE
$56.66
-$1.80-3.08%
NYSE
| 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.66% | 13.67% | -41.31% | 54.64% | 10.83% |
| Total Depreciation and Amortization | -3.08% | -1.75% | 33.71% | -25.90% | -0.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.36% | 81.33% | 194.95% | -184.53% | -4.35% |
| Change in Net Operating Assets | -54.74% | 147.02% | -235.35% | 216.06% | -29.08% |
| Cash from Operations | -15.95% | 539.96% | -85.08% | 166.32% | -10.36% |
| Capital Expenditure | -26.57% | -33.62% | 76.00% | -83.04% | 9.40% |
| Sale of Property, Plant, and Equipment | 260.00% | -59.60% | -87.88% | 876.49% | 32.80% |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.91% | 13.44% | -144.99% | -32.87% | 26.62% |
| Cash from Investing | 3.29% | 7.67% | -282.93% | 203.85% | 25.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.06% | 0.06% | 0.00% | -0.06% | -- |
| Issuance of Common Stock | 5,884.13% | -98.40% | 2,712.86% | -96.05% | 1,310.36% |
| Repurchase of Common Stock | 99.79% | -1,469.00% | 96.81% | -33,307.57% | 99.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.10% | -8.33% | -33.33% | 81.88% | -1,254.55% |
| Cash from Financing | 102.66% | -3,034.81% | 98.39% | -11,074.64% | 101.84% |
| Foreign Exchange rate Adjustments | 204.79% | -118.48% | 50.97% | 144.59% | -247.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,797.42% | 125.45% | 1.55% | -165.31% | 147.76% |